Disclosures: Jain reports she is a paid freelance writer for Lippincott. Kumthekar reports no relevant financial disclosures.
August 09, 2021
35 min listen
Save

Applying Translational Oncology to Work-Life Integration with Priya U. Kumthekar, MD

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Kumthekar reports no relevant financial disclosures.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In this episode, Priya U. Kumthekar, MD, discusses her entry into the field of neuro-oncology, her insight into translational medicine and its applications outside of medicine, and more.

  • Welcome to another exciting episode of Oncology Overdrive :14
  • About Kumthekar :28
  • The interview 1:51
  • How did you become a neuro-oncologist? 1:57
  • What do you think is so great about being able to translate what we’re able do at work to how we live at home? 5:29
  • The importance of transparency at home 9:20
  • What do you do for your own mental health? 13:13
  • Do you think that after this last year and a half are there going to be things that stick with you after this pandemic that have permanently changed you? 16:46
  • How did you manage virtual learning with your kids and everything else that you were doing? 20:16
  • Do you foresee changes in the health care system in the practice of oncology? 23:53
  • Is there anything that you say to yourself or do for yourself when you’re at your breaking point? 28:30
  • Kumthekar’s one pearl 33:26
  • How to contact Kumthekar 34:18

Priya U. Kumthekar, MD, is an associate professor of neurology (neuro-oncology) and medicine (hematology and oncology) at Northwestern Medicine. Kumthekar is a UCNS-certified neuro-oncologist dedicated to patient care, moving the field of oncology forward primarily through her leadership on brain metastases and primary brain tumor clinical trials.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Kumthekar can be reached by email at priya.kumthekar@nm.org.